scPharmaceuticals (SCPH)
(Real Time Quote from BATS)
$4.57 USD
+0.06 (1.33%)
Updated Apr 19, 2024 12:45 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.35 |
Last EPS Surprise | 16.67% |
ABR | 1.00 |
Earnings ESP
|
-1.47% |
---|---|
Current Year | -1.47 |
Next Year | -0.66 |
EPS (TTM) | -1.42 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.50M | 8.61M | 41.49M | 104.67M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 7.50M | 9.40M | 45.60M | 134.70M |
Low Estimate | 5.90M | 8.20M | 39.00M | 81.91M |
Year ago Sales | 2.06M | 1.64M | 13.59M | 41.49M |
Year over Year Growth Est. | 215.68% | 424.76% | 205.23% | 152.27% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.41 | -1.47 | -0.66 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.45 | -0.42 | -1.53 | -0.71 |
High Estimate | -0.39 | -0.35 | -1.30 | -0.26 |
Low Estimate | -0.51 | -0.49 | -1.75 | -1.15 |
Year ago EPS | -0.30 | -0.36 | -1.42 | -1.47 |
Year over Year Growth Est. | -50.00% | -13.89% | -3.52% | 55.27% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 2 | 2 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.41 | -1.47 | -0.66 |
7 Days Ago | -0.45 | -0.41 | -1.47 | -0.66 |
30 Days Ago | -0.45 | -0.42 | -1.39 | -0.61 |
60 Days Ago | -0.38 | -0.35 | -1.24 | -0.56 |
90 Days Ago | -0.32 | -0.28 | -1.20 | -0.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.46 | -0.40 | -1.52 | -0.87 |
Zacks Consensus Estimate | -0.45 | -0.41 | -1.47 | -0.66 |
Earnings ESP | -1.47% | 3.23% | -3.40% | -32.32% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.35 | -0.41 | -0.36 | -0.30 | NA |
Estimate | -0.42 | -0.36 | -0.37 | -0.36 | NA |
Difference | 0.07 | -0.05 | 0.01 | 0.06 | 0.02 |
Surprise | 16.67% | -13.89% | 2.70% | 16.67% | 5.54% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more